@Coolfundoo 🌟25 , 22, 20, 19
2
The absolute best 15 scanners which experts are using.
— Aditya Todmal (@AdityaTodmal) January 29, 2021
Got these scanners from the following accounts:
1. @Pathik_Trader
2. @sanjufunda
3. @sanstocktrader
4. @SouravSenguptaI
5. @Rishikesh_ADX
Share for the benefit of everyone.
\U0001f4e2Stocks where 2 or more Superstar Shareholders have investment as of Dec-2021 (latest data)
— Sachin K Rai (@Coolfundoo) February 15, 2022
Hope this helps in your decision making !
If you find this useful feel free to share & re-tweet !@abhymurarka pic.twitter.com/2VU2OVvamX
Today at 2 pm:
— Kunal Bothra (@kbbothra) July 5, 2022
I will bring to you one of the SUPER FINEST TECHNICAL CHART setup on a largecap name.
Agar yeh nahi chal paya toh kuch nahi chal paayega\u2026
Retweeet tsunami has to come for this one\u2026 #stock #breakout #technical
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz